Untitled - Roche Trasplantes

PROTOCOL BIOPSIES AND THE DIAGNOSIS OF HUMORAL REJECTION
vent acute humoral allograft rejection. Protocol biopsies appear to be an adequate tool
for monitoring the natural course of humoral immune responses and all prospective clinical
trials testing new drugs for the treatment of manifest humoral rejection episodes
should include protocol biopsies. Furthermore, protocol biopsies should also allow for a
timely therapeutic intervention ones intragraft signs of accommodation and humoral rejection
are adequately understood.
REFERENCES
1. Bohmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, et al. Capillary
C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft
injury. J Am Soc Nephrol 2002; 13 (4): 1091-9.
2. Bohmig GA, Exner M, Watschinger B, Wenter C, Wahrmann M, Osterreicher C, et
al. C4d deposits in renal allografts are associated with inferior graft outcome. Transplant
Proc 2001; 33 (1-2): 1151-2.
3. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol
2005; 5 (10): 807-17.
4. Feucht HE, Felber E, Gokel MJ, Hillebrand G, Nattermann U, Brockmeyer C, et al.
Vascular deposition of complement-split products in kidney allografts with cell-mediated
rejection. Clin Exp Immunol 1991; 86 (3): 464-70.
5. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmuller G, et
al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney
Int 1993; 43 (6): 1333-8.
6. Feucht HE, Lederer SR, Kluth B. Humoral alloreactivity in recipients of renal allografts
as a risk factor for the development of delayed graft function. Transplantation 1998;
65 (5): 757-8.
7. Fidler ME, Gloor JM, Lager DJ, Larson TS, Griffin MD, Textor SC, et al. Histologic findings
of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney
transplantation. Am J Transplant 2004; 4 (1): 101-7.
8. Fiebeler A, Mengel M, Merkel S, Haller H, Schwarz A. Diffuse C4d deposition and
morphology of acute humoral rejection in a stable renal allograft. Transplantation 2003;
76 (7): 1132-3.
9. Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of
the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-
mediated rejection. Transplantation 1990; 49 (1): 85-91.
10. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response.
II. Clinical and pathologic features of renal transplants with anti-class I-like
antibody. Transplantation 1992; 53 (3): 550-5.
11. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an
independent long-term prognostic factor. J Am Soc Nephrol 2002; 13 (1): 234-41.
12. Ivanyi B. Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers
of chronic renal allograft rejection. Nephrol Dial Transplant 2003; 18 (4): 655-60.
67